<DOC>
	<DOC>NCT01367249</DOC>
	<brief_summary>This is an efficacy study of Bromfenac Ophthalmic Solution in cataract surgery.</brief_summary>
	<brief_title>Efficacy of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bromfenac</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Male or female at least 18 years of age who are scheduled for unilateral cataract surgery Have known hypersensitivity to bromfenac or to any component of the investigational product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>cataract surgery</keyword>
</DOC>